Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1039/d5md00902b

http://scihub22266oqcxt.onion/10.1039/d5md00902b
suck pdf from google scholar
C12694745!12694745 !41384053
unlimited free pdf from europmc41384053
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid41384053
      RSC+Med+Chem 2025 ; ? (?): ?
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Developing pyrazole-oxadiazole conjugates as potent anti-tubercular agents: an in silico and in vitro approach #MMPMID41384053
  • Kumar SA ; Besra G ; Batt S ; Chandrashekar VM ; Singh M ; Akshatha HS ; Bhagyalalitha M ; Pujar KG ; Bidye D ; Madhukumari ; Pujar GV
  • RSC Med Chem 2025[Dec]; ? (?): ? PMID41384053 show ga
  • Decaprenylphosphoryl-beta-d-ribose 2'-oxidase (DprE1) is a unique enzyme in Mycobacterium tuberculosis (Mtb) essential for the synthesis of the cell wall constituent arabinan. It converts decaprenyl phosphoryl ribose (DPR) to decaprenyl phosphoryl arabinose (DPA) with DprE2. Inhibition of DprE1 affects the integrity of the cellular membrane, causing cell wall rupture, leakage of cellular contents, and ultimately, cell death. Structural analysis of the DprE1 binding site reveals three binding regions: hydrophobic head region, planar core nucleus, and solvent-accessible tail region. Based on these structural features and reported inhibitors, structure-based drug design (SBDD) was employed to design and develop 22 novel pyrazole-oxadiazole conjugates (PO1-PO22), combining a hydrophobic pyrazole and planar oxadiazole connected to an amide linker. The designed compounds were synthesized and evaluated for antitubercular activity against the Mtb H37Rv strain using the Microplate Alamar Blue (MAB) assay. Among them, PO3 and PO4 exhibited potent activity with MIC values of 0.24 and 0.53 ?M, respectively, better than the known DprE1 inhibitor TCA-1 (MIC 0.66 ?M). Six compounds with MICs < 2.5 ?M were further screened for DprE1 inhibition. PO3 and PO4 showed IC(50) values of 32.7 ± 6.0 and 39.2 ± 7.3 ?M, suggesting DprE1 may not be their primary target. Molecular dynamics simulations (200 ns) supported the limited stability of DprE1-ligand complexes. Notably, the active compounds displayed excellent safety (IC(50) > 500 ?M) in NIH/3T3 fibroblast cytotoxicity assays. Overall, the pyrazole-oxadiazole conjugates represent promising anti-Mtb agents, likely acting through multi-target mechanisms within the pathogen.
  • ?


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box